Agent for transdermal administration containing ergoline derivatives

US5399355A · kind A · utility

Assignee

• SCHERING CORPORATION · US

Inventors

• Jutta Riedl · Berlin, DE
• Clements Gunther · Berlin, DE
• Ralph Lipp · Berlin, DE

Key dates

• Filing date: Mar 30, 1993
• Grant date: Mar 21, 1995
• Expiry date: Mar 30, 2013

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K31/48
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

An agent for transdermal administration contains ergoline derivatives optionally in combination with one or more penetration-enhancing agent or agents.